FCA
CRBU icon

FinTrust Capital Advisors’s Caribou Biosciences CRBU Stock Holding History

FinTrust Capital Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$1K – 1226
2022
Q1 		$1K Buy
+100
New +$1.05K ﹤0.01% 1165

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

FinTrust Capital Advisors's CRBU Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of Caribou Biosciences (CRBU) in Q2 2022, closing a stake of 100 shares — an estimated $1K sold.

FinTrust Capital Advisors first reported a position in CRBU in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 120 funds tracked by Wall St. Rank hold CRBU as of Q2 2022.

  • FinTrust Capital Advisors reported no remaining Caribou Biosciences position as of Q2 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 100 Caribou Biosciences shares in Q2 2022, an estimated $1K.
  • FinTrust Capital Advisors first reported a position in Caribou Biosciences in Q1 2022 and held it in 1 quarter.
  • FinTrust Capital Advisors's Caribou Biosciences position peaked at $1K in Q1 2022.
  • 120 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.